Takeda announced the signing of a new Memorandum of Understanding (MoU) with the Saudi Gastroenterology Association (SGA). This partnership brings together Takeda’s global expertise in gastroenterology and SGA’s recognized local leadership, with the collective goal of advancing the quality of care for individuals living with Inflammatory Bowel Disease (IBD) across Saudi Arabia.
“As studies highlight the rising prevalence of IBD in Saudi Arabia, it is essential that our medical community has access to the most advanced knowledge, tools, and resources,” said Prof. Majid Almadi, President of the Saudi Gastroenterology Association. “This partnership with Takeda will support enhancing our ability to deliver high-quality care by equipping healthcare professionals with advanced education, global expertise, and the latest scientific insights.”
“This agreement represents another important step in our ongoing commitment to supporting healthcare transformation in Saudi Arabia,” said Khaled Sary, General Manager, West Gulf Cluster at Takeda. “By aligning global innovation with national priorities, we aim to play a meaningful role in developing sustainable, patient-centered solutions for IBD care.”
Click here to join our WhatsApp channel here
Beyond professional development, the partnership will champion environmental sustainability as part of both organizations’ dedication to corporate social responsibility. The MoU reflects a shared commitment to ensuring IBD patient care grows in step with international best practices and accommodates the needs of the Saudi population – demonstrating ongoing dedication to both patient well-being and a healthier planet.
